Defendants' Appendix to Opposition to Motion for a Class-Wide Preliminary Injunction — Navy SEALs 1-26
Summary
Defendants' appendix to their opposition to plaintiffs' motion for a class-wide preliminary injunction in NAVY SEALS 1-26 against Lloyd J. Austin, III, United States Secretary of Defense, in the United States District Court for the Northern District of Texas (Case No. 4:21-cv-01236-O). A table lists Ex. 1 through Ex. 4 as declarations of Admiral Daryl L. Caudle, Vice Admiral William Merz, Captain Joon Yun and Rear Admiral Gayle D. Shaffer, dated February 23, 2022. Exhibit A to the Yun declaration says that by September 2021, SARS-CoV-2 infection rates among unvaccinated personnel were approximately four times that of vaccinated personnel, and that no deaths occurred in fully vaccinated US Navy or Marine Corps personnel.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
- Date
- 2022-02-23
Cite this document
“Defendants' Appendix to Opposition to Motion for a Class-Wide Preliminary Injunction — Navy SEALs 1-26.”
Original at archive.org, dated 2022-02-23. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2022-02-23-plaintiffs-v-lloyd-j-austin-iii-in-his-official-capacity-as-999af7ff-1/
, SHA-256 999af7ff0eb2c606bac206240ff12412a99220058fdf7fc97ef87cff6bd719a2.Full text
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS NAVY SEALS 1-26, et al., Plaintiffs, v. LLOYD J. AUSTIN, III, in his official capacity as United States Secretary of Defense, et al., Defendants. Case No. 4:21-cv-01236-O DEFENDANTS’ APPENDIX TO DEFENDANTS’ OPPOSITION TO PLAINTIFFS’ MOTION FOR A CLASS-WIDE PRELIMINARY INJUNCTION Table of Appendix Bates Stamps Description App001–App018 Ex. 1 - Declaration of Admiral Daryl L. Caudle App019–App024 Ex. 2 - Declaration of Vice Admiral William Merz App025–App035 Ex. 3 - Declaration of Captain Joon Yun App036–App043 Ex. 4 - Declaration of Rear Admiral Gayle D. Shaffer Dated: February 23, 2022 Respectfully submitted, BRIAN M. BOYNTON Principal Deputy Assistant Attorney General ALEXANDER K. HAAS Director, Federal Programs Branch ANTHONY J. COPPOLINO Deputy Director /s/Amy E. Powell ANDREW E. CARMICHAEL AMY E. POWELL Senior Trial Counsel STUART J. ROBINSON Senior Counsel ZACHARY A. AVALLONE COURTNEY D. ENLOW (NC Bar No. 46578) LIAM HOLLAND Trial Attorneys Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 1 of 46 PageID 4108 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 1 of 46 PageID 4108 United States Department of Justice Civil Division, Federal Programs Branch 1100 L Street, N.W. Washington, DC 20005 Tel: (202) 616-8467 Fax: (202) 616-8470 Email: courtney.d.enlow@usdoj.gov Counsel for Defendants Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 2 of 46 PageID 4109 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 2 of 46 PageID 4109 CERTIFICATE OF SERVICE I hereby certify that on February 23, 2022, I electronically filed the foregoing paper with the Clerk of Court using this Court’s CM/ECF system, which will notify all counsel of record of such filing. /s/Amy Powell AMY E. POWELL Senior Trial Counsel United States Department of Justice Civil Division, Federal Programs Branch 150 Fayetteville St, Suite 2100 Raleigh, NC 27601 Tel: (919) 856-4013 Fax: (202) 616-8470 Email: amy.powell@usdoj.gov Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 3 of 46 PageID 4110 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 3 of 46 PageID 4110 Exhibit 1 App001 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 4 of 46 PageID 4111 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 4 of 46 PageID 4111 App002 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 5 of 46 PageID 4112 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 5 of 46 PageID 4112 App003 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 6 of 46 PageID 4113 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 6 of 46 PageID 4113 App004 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 7 of 46 PageID 4114 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 7 of 46 PageID 4114 App005 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 8 of 46 PageID 4115 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 8 of 46 PageID 4115 App006 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 9 of 46 PageID 4116 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 9 of 46 PageID 4116 App007 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 10 of 46 PageID 4117 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 10 of 46 PageID 4117 App008 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 11 of 46 PageID 4118 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 11 of 46 PageID 4118 App009 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 12 of 46 PageID 4119 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 12 of 46 PageID 4119 App010 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 13 of 46 PageID 4120 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 13 of 46 PageID 4120 App011 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 14 of 46 PageID 4121 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 14 of 46 PageID 4121 App012 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 15 of 46 PageID 4122 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 15 of 46 PageID 4122 App013 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 16 of 46 PageID 4123 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 16 of 46 PageID 4123 App014 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 17 of 46 PageID 4124 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 17 of 46 PageID 4124 App015 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 18 of 46 PageID 4125 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 18 of 46 PageID 4125 App016 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 19 of 46 PageID 4126 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 19 of 46 PageID 4126 App017 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 20 of 46 PageID 4127 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 20 of 46 PageID 4127 App018 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 21 of 46 PageID 4128 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 21 of 46 PageID 4128 Exhibit 2 App019 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 22 of 46 PageID 4129 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 22 of 46 PageID 4129 App020 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 23 of 46 PageID 4130 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 23 of 46 PageID 4130 App021 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 24 of 46 PageID 4131 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 24 of 46 PageID 4131 App022 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 25 of 46 PageID 4132 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 25 of 46 PageID 4132 App023 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 26 of 46 PageID 4133 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 26 of 46 PageID 4133 App024 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 27 of 46 PageID 4134 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 27 of 46 PageID 4134 Exhibit 3 App025 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 28 of 46 PageID 4135 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 28 of 46 PageID 4135 App026 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 29 of 46 PageID 4136 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 29 of 46 PageID 4136 App027 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 30 of 46 PageID 4137 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 30 of 46 PageID 4137 App028 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 31 of 46 PageID 4138 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 31 of 46 PageID 4138 App029 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 32 of 46 PageID 4139 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 32 of 46 PageID 4139 App030 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 33 of 46 PageID 4140 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 33 of 46 PageID 4140 App031 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 34 of 46 PageID 4141 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 34 of 46 PageID 4141 Exhibit A to CAPT Yun Declaration App032 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 35 of 46 PageID 4142 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 35 of 46 PageID 4142 1. Data concerning health to force/personnel • Transmission rates, especially comparisons of vaccinated/unvaccinated, and especially if known WRT known ship outbreaks In the early days of the pandemic, there were no vaccines available. At that time, the US Navy experienced several significant COVID-19 outbreaks aboard ships causing widespread mission disruption, hospitalizations and a death. Restriction of Movement (ROM) policies such as pre-deployment ROM-Sequester, isolation and quarantine, as well as widespread aggressive testing policies were enacted to prevent COVID-19 introduction onto ships so as to preserve mission capability. The costs in terms of lost duty time and diversion of assets for testing were extensive. COVID-19 rates were significantly reduced with the introduction of vaccination, allowing for the elimination of ROM-sequester and ship-wide testing strategies. Figure 1. App033 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 36 of 46 PageID 4143 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 36 of 46 PageID 4143 By September 2021, SARS-CoV-2 infection rates among unvaccinated personnel were approximately four times that of vaccinated personnel (Figure 1). Importantly, severity of disease was also dramatically reduced. Figure 2 below, current through 8 Feb2022, shows the total numbers of cases, hospitalizations, and deaths by vaccination status. There is a clear reduction in both hospitalizations and deaths with vaccination status, with no deaths occurring in fully vaccinated US Navy or Marine Corps personnel and only ten hospitalizations (4 US Navy, 6 US Marine Corps). Figure 2. Number of COVID-19 Cases % Number of COVID-19 Cases % Number of COVID-19 Cases % Vaccination Status¹ Severe Case² No Yes-Hospitalized 78 0.29% 96 0.21% 174 0.24% Yes-Death 2 0.01% 8 0.02% 10 0.01% No 15,050 55.33% 27,035 60.44% 42,085 58.51% Yes-Hospitalized 6 0.02% 4 0.01% 10 0.01% Yes-Death 0 0.00% 0 0.00% 0 0.00% No 390 1.43% 1,931 4.32% 2,321 3.23% Yes-Hospitalized 0 0.00% 0 0.00% 0 0.00% Yes-Death 0 0.00% 0 0.00% 0 0.00% 27,200 100.00% 44,729 100.00% 71,929 100.00% Prepared by the EpiData Center Department, Navy and Marine Corps Public Health Center, 09FEB2022. All hospitalized cases among fully immunized and boosted service members are manually reviewed by a clinician. Hospitalizations among not fully immunized service members are not manually reviewed. Department of the Navy Active Duty: Total COVID-19 Case Occurrence by Vaccination Status¹ 17DEC2020-08FEB2022 ¹ Two vaccine doses were considered complete for the Pfizer-BioNTech and Moderna COVID-19 vaccines, and one vaccine dose was considered complete for the J&J/Janssen COVID-19 vaccine. Individuals were considered fully vaccinated 14 days after receipt of the final dose. An individual was considered not fully immunized if they did not receive any vaccine doses, have only received a partial series, or have not yet reached 14 days after the completion of their vaccine series. COVID-19 vaccines with an error in the Medical Readiness Reporting System were removed from this analysis. ² Severe COVID-19 case defined as hospitalization or death reported in the Armed Forces Health Surveillance Division COVID-19 Master Positive List. Data Source: Medical Readiness Reporting System, Armed Forces Health Surveillance Division COVID-19 Master Positive List. 37.99% Not fully immunized¹ prior to the COVID-19 incident date Fully immunized¹ but not boosted: COVID-19 incident date >=14 days after final dose of regular series, no booster Boosted: COVID-19 incident date >=7 days after receiving booster Total 11,674 42.92% 15,655 35.00% 27,329 Vaccination Status¹ and Severity² Service Total Marine Corps Navy App034 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 37 of 46 PageID 4144 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 37 of 46 PageID 4144 App035 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 38 of 46 PageID 4145 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 38 of 46 PageID 4145 Exhibit 4 App036 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 39 of 46 PageID 4146 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 39 of 46 PageID 4146 App037 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 40 of 46 PageID 4147 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 40 of 46 PageID 4147 App038 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 41 of 46 PageID 4148 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 41 of 46 PageID 4148 App039 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 42 of 46 PageID 4149 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 42 of 46 PageID 4149 App040 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 43 of 46 PageID 4150 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 43 of 46 PageID 4150 App041 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 44 of 46 PageID 4151 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 44 of 46 PageID 4151 App042 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 45 of 46 PageID 4152 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 45 of 46 PageID 4152 App043 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 46 of 46 PageID 4153 Case 4:21-cv-01236-O Document 130 Filed 02/23/22 Page 46 of 46 PageID 4153
File and source
- File
- gov.uscourts.txnd.355696.130.0.pdf
- Size
- 5,133,017 bytes
- SHA-256
- 999af7ff0eb2c606bac206240ff12412a99220058fdf7fc97ef87cff6bd719a2
- Original
- archive.org